Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study-Reference-Cited by-同舟云学术

Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study

Published:2012-03-02 Issue:8 Volume:27 Page:3270-3278
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Ketteler M.,Martin K. J.,Wolf M.,Amdahl M.,Cozzolino M.,Goldsmith D.,Sharma A.,Marx S.,Khan S.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/27/8/3270/7637777/gfs018.pdf

Reference28 articles.

1. The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism

2. Outcomes of Secondary Hyperparathyroidism in Chronic Kidney Disease and the Direct Costs of Treatment

3. Metabolic Bone Disease in Chronic Kidney Disease

4. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

5. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent uncertainties in optimal treatment approaches of secondary hyperparathyroidism and hyperphosphatemia in patients with chronic kidney disease;Current Osteoporosis Reports;2024-08-19

2. Effects of active vitamin D analogs and calcimimetic agents on PTH and bone mineral biomarkers in hemodialysis patients with SHPT: a network meta-analysis;European Journal of Clinical Pharmacology;2024-07-13

3. Renal Osteodystrophy: Clinical Management;Endocrinology;2023-12-19

4. Calcitriol Versus Calcitriol and Low Dose Cinacalcet for Treating Severe Secondary Hyperparathyroidism in Hemodialysis Patients: A Randomized Clinical Trial;Journal of Kermanshah University of Medical Sciences;2023-08-06

5. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM);Nefrología (English Edition);2023-06